T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Humana
HUM
|
+$2.39B |
| 2 |
UnitedHealth
UNH
|
+$1.47B |
| 3 |
GE Aerospace
GE
|
+$1.33B |
| 4 |
Amazon
AMZN
|
+$1.18B |
| 5 |
AbbVie
ABBV
|
+$1.13B |
Top Sells
| 1 |
Boeing
BA
|
+$1.56B |
| 2 |
Nike
NKE
|
+$1.42B |
| 3 |
Becton Dickinson
BDX
|
+$1.33B |
| 4 |
Alibaba
BABA
|
+$1.23B |
| 5 |
JPMorgan Chase
JPM
|
+$1.22B |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Corning
GLW
$61.8B
| $512M | 0.08% |
24,943,210
-75,876
| -0.3% | -$1.56M |
|
252
argenx
ARGX
$47B
| $511M | 0.08% |
3,880,174
-149,302
| -4% | -$19.7M |
|
253
Skyworks Solutions
SWKS
$11.2B
| $510M | 0.08% |
5,702,980
-893,202
| -14% | -$79.8M |
|
254
Magna International
MGA
$13B
| $508M | 0.08% |
15,913,018
-3,031,962
| -16% | -$96.8M |
|
|
RP
255
DELISTED
RealPage, Inc.
RP
| $506M | 0.08% |
9,566,076
+185,982
| +2% | +$9.84M |
|
256
Sensata Technologies
ST
$4.66B
| $502M | 0.08% |
17,364,523
-148,888
| -0.9% | -$4.31M |
|
257
Acadia Pharmaceuticals
ACAD
$4.28B
| $500M | 0.08% |
11,827,905
-1,413,109
| -11% | -$59.7M |
|
258
Boston Beer
SAM
$2.45B
| $499M | 0.08% |
1,356,246
-12,734
| -0.9% | -$4.68M |
|
259
Entergy
ETR
$38.8B
| $496M | 0.08% |
10,557,180
-4,528,446
| -30% | -$213M |
|
260
Regeneron Pharmaceuticals
REGN
$59.2B
| $492M | 0.08% |
1,007,333
+216,210
| +27% | +$106M |
|
261
Rollins
ROL
$27.7B
| $492M | 0.08% |
20,405,327
+733,785
| +4% | +$17.7M |
|
262
Molina Healthcare
MOH
$9.51B
| $491M | 0.08% |
3,511,424
-157,523
| -4% | -$22M |
|
263
Gartner
IT
$18.7B
| $489M | 0.08% |
4,906,205
-1,120,808
| -19% | -$112M |
|
264
Rayonier
RYN
$4.1B
| $486M | 0.08% |
21,667,649
+415,030
| +2% | +$9.3M |
|
265
TAL Education Group
TAL
$6.32B
| $484M | 0.08% |
9,085,397
+3,379,874
| +59% | +$180M |
|
266
CF Industries
CF
$13.7B
| $479M | 0.08% |
17,603,196
-4,599,758
| -21% | -$125M |
|
267
Ulta Beauty
ULTA
$23.3B
| $473M | 0.07% |
2,692,330
+379,928
| +16% | +$66.8M |
|
268
Lennox International
LII
$20.4B
| $470M | 0.07% |
2,584,765
-292,523
| -10% | -$53.2M |
|
|
NVRO
269
DELISTED
NEVRO CORP.
NVRO
| $466M | 0.07% |
4,663,485
+1,980,647
| +74% | +$198M |
|
270
Sherwin-Williams
SHW
$93.6B
| $463M | 0.07% |
3,021,696
-152,868
| -5% | -$23.4M |
|
271
Loews
L
$19.9B
| $462M | 0.07% |
13,256,025
+1,097,270
| +9% | +$38.2M |
|
272
TE Connectivity
TEL
$61.4B
| $452M | 0.07% |
7,172,870
-770,614
| -10% | -$48.5M |
|
273
MGM Resorts International
MGM
$9.85B
| $442M | 0.07% |
37,443,549
-16,079,440
| -30% | -$190M |
|
274
Treehouse Foods
THS
$905M
| $441M | 0.07% |
9,991,414
-5,021
| -0.1% | -$222K |
|
275
Progressive
PGR
$144B
| $441M | 0.07% |
5,967,188
+15,447
| +0.3% | +$1.14M |
|